<DOC>
	<DOC>NCT01928628</DOC>
	<brief_summary>This study aims to compare and assess the efficacy and the safety of the combination agent of Lercanidipine and Valsartan and monotherapy of Lercanidipine alone in patients with essential hypertension</brief_summary>
	<brief_title>Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Lercanidipine</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Patients aged ≥ 20 to ≤75 years old Patient with essential hypertension When the BP level measured at screening was sitDBP&gt;120 mmHg or sitSBP &gt;180 mmHg Patient with difference in repeatedly measured blood pressures from the selected arm at screening was sitSBP≥ 20mmHg or sitDBP ≥ 10mmHg</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>